Cramer Rosenthal Mcglynn LLC Bio Techne Corp Transaction History
Cramer Rosenthal Mcglynn LLC
- $1.77 Billion
- Q1 2024
A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 380,802 shares of TECH stock, worth $27.1 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
380,802
Previous 233,274
63.24%
Holding current value
$27.1 Million
Previous $18 Million
48.92%
% of portfolio
1.52%
Previous 1.01%
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
581Shares Held
154MCall Options Held
180KPut Options Held
189K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.3 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY17.7MShares$1.27 Billion0.03% of portfolio
-
State Street Corp Boston, MA6.37MShares$454 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.75MShares$410 Million0.05% of portfolio
-
Bamco Inc New York, NY5MShares$356 Million0.95% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.8B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...